Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2000
Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptaseP L Boyer, S G Sarafianos, E Arnold, et al.Journal of Virology|April 20, 2001
Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptaseP L Boyer, S G Sarafianos, E Arnold, et al.Journal of Virology|June 20, 2001
Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptaseJ G Julias, A L Ferris, P L Boyer, et al.AIDS Research and Human Retroviruses|August 1, 1994
Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitorsS Loya, M Bakhanashvili, R Tal, et al.Journal of Molecular Biology|June 30, 2000
The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptaseH Q Gao, P L Boyer, S G Sarafianos, et al.Virology|March 22, 2001
The basic loop of the RNase H domain of MLV RT is important both for RNase H and for polymerase activityP L Boyer, H Q Gao, P Frank, et al.Journal of Virology|April 1, 1993
Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptaseP L Boyer, M J Currens, J B McMahon, et al.Journal of Virology|July 1, 1997
Subunit-specific mutagenesis of the cysteine 280 residue of the reverse transcriptase of human immunodeficiency virus type 1: effects on sensitivity to a specific inhibitor of the RNase H activityS Loya, H Q Gao, O Avidan, et al.Chemistry & Biology|May 14, 1999
Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active siteS G Sarafianos, K Das, J Ding, et al.Proceedings of the National Academy of Sciences of the United States of America|November 13, 1998
Hybrid Ty1/HIV-1 elements used to detect inhibitors and monitor the activity of HIV-1 reverse transcriptaseD V Nissley, P L Boyer, D J Garfinkel, et al.Pageof 4